Johnson & Johnson (J&J) and subsidiaries Janssen Pharmaceuticals Inc. and Scios Inc. will pay $2.2 billion to the U.S. government and 45 states to resolve criminal and civil claims in multiple settlement agreements with the U.S. Department of Justice (DOJ) and 45 states.